Delivery Order SPE2DB22D2006-SPE2DB25FW2YH
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pens valued at $1,174.39 with a firm fixed price structure. This competitively awarded, non-set-aside contract became effective on July 31, 2025, with an ultimate completion date of August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,545.30 for Trulicity 1.5 mg/0.5 ml pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical transaction under AmerisourceBergen's broader federal contract portfolio. The product will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, represents pharmaceutical procurement under the company's larger contract vehicle with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens in 0.5 mL units. This firm fixed-price contract, valued at $1,734.90, represents a competitive award with no set-aside designation and is scheduled for completion by July 23, 2025. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is executed...
- The Defense Logistics Agency awarded a $3,073.44 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Trulicity 0.75 mg/0.5 mL pens on July 24, 2025. The contract, valued at $1,889.60 with a firm fixed price structure, represents a single delivery order under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). This award was competitively made with no set-aside designation...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Trulicity 0.75 mg/0.5 ml pens. The $2,437.92 contract has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 ml pens valued at $1,417.72 on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle running through December 2026. The product will be...
- The Defense Logistics Agency awarded a $5,756.58 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on July 23, 2025, with completion scheduled for July 24, 2025. This firm fixed-price contract is a non-set-aside competitive award and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,907.92 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on July 18, 2025. This competitively awarded, firm fixed price delivery order is scheduled for completion by July 21, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract involves no set-aside designation and is issued as a child order under AmerisourceBergen's larger indefinite...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW2YHDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 ml pens valued at $5,236.50 on July 29, 2025, with completion scheduled for July 30, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be delivered to the company's distribution facility in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems globally. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare operations. The contract demonstrates the company's capability to fulfill federal requirements for brand-name medications across multiple therapeutic domains, including diabetes treatments like Trulicity, through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 7/29/25 |